Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
To reduce the burden of Cardiovascular Diseases by improving the standard of care in oncology patients and cancer survivors treated with cardiotoxic cancer therapies or radiotherapy
Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines
RESILIENCE is a Horizon 2020 project testing the efficacy of a novel intervention to reduce AC-induced HF, new MRI sequences as a marker of cardiotoxicity and a protocol for patients’ empowerment in the research development.
Our mission: To reduce the burden of cardiovascular disease.